Uganda receives 19,200 doses of twice-yearly injectable HIV prevention drug, but when and where will it be rolled out?

Uganda has received 19,200 doses of Lenacapavir, a new long-acting HIV prevention drug that is taken only twice a year and is more than 99 per cent effective. The consignment, delivered on Tuesday, February 24, was secured with support from the Global Fund and will be rolled out to districts with high HIV infection rates The post Uganda receives 19,200 doses of twice-yearly injectable HIV prevention drug, but when and where will it be rolled out? first appeared on Matooke Republic.